- Company Directors - K
- Klingenstein Paul H
Insider Trading History of Klingenstein Paul H
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Klingenstein Paul H since 2007.
The trader's CIK number is 935463.
At the time of the last reporting, Klingenstein Paul H was the Director of Clovis Oncology, Inc.. (stock ticker symbol CLVS).
Also see all insider trading activities at Clovis Oncology, Inc..
Note that in the past
KLINGENSTEIN PAUL H also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Histogen Inc. (CNAT) by Klingenstein Paul H
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | CNAT | 107,422 | $1,181,642 | 566 | $6,226 | 0 | $0 |
Yearly summary of insider trading at Clovis Oncology, Inc. (CLVS) by Klingenstein Paul H
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | CLVS | 0 | $0 | 0 | $0 | 25,862 | $7,499 |
| 2011 | CLVS | 399,291 | $5,190,783 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Reshape Lifesciences Inc. (ETRM) by Klingenstein Paul H
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | ETRM | 1,237,113 | $1,422,679 | 0 | $0 | 0 | $0 |
| 2008 | ETRM | 242,200 | $1,117,000 | 0 | $0 | 0 | $0 |
| 2007 | ETRM | 250,000 | $2,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Anacor Pharmaceuticals Inc (ANAC) by Klingenstein Paul H
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2010 | ANAC | 300,000 | $1,500,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Klingenstein Paul H:
1. Histogen Inc. (CNAT)
2. Clovis Oncology, Inc. (CLVS)
3. Reshape Lifesciences Inc. (ETRM)
4. Anacor Pharmaceuticals Inc (ANAC)
Table 1. Insider trading of Histogen Inc. (CNAT) by Klingenstein Paul H
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-07-30 | CNAT | Buy | 107,422 | 11.00 | 1,181,642 |
| 2013-07-30 | CNAT | Sale | 566 | 11.00 | 6,226 |
Table 2. Insider trading of Clovis Oncology, Inc. (CLVS) by Klingenstein Paul H
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-07-29 | CLVS | Option Ex | 25,862 | .29 | 7,499 |
| 2011-11-21 | CLVS | Buy | 399,291 | 13.00 | 5,190,783 |
Table 3. Insider trading of Reshape Lifesciences Inc. (ETRM) by Klingenstein Paul H
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-02-24 | ETRM | Buy | 1,237,113 | 1.15 | 1,422,679 |
| 2008-05-29 | ETRM | Buy | 12,200 | 4.50 | 54,900 |
| 2008-06-02 | ETRM | Buy | 80,000 | 4.50 | 360,000 |
| 2008-05-23 | ETRM | Buy | 50,000 | 4.50 | 225,000 |
| 2008-05-19 | ETRM | Buy | 70,000 | 4.78 | 334,600 |
| 2008-05-20 | ETRM | Buy | 30,000 | 4.75 | 142,500 |
| 2007-11-15 | ETRM | Buy | 250,000 | 8.00 | 2,000,000 |
Table 4. Insider trading of Anacor Pharmaceuticals Inc (ANAC) by Klingenstein Paul H
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2010-11-30 | ANAC | Buy | 300,000 | 5.00 | 1,500,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Klingenstein Paul H
(Director of Clovis Oncology, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.